• BX Home
  • Pharmaceutical Approvals: Blog [Page 3]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

PHARMACEUTICAL APPROVALS

Pharmaceuticals approvals are the last step in a long process of government testing. This topic tracks the approval of prescription and over-the-counter pharmaceuticals.

Pharmaceutical Approvals is part of Business Exchange, suggested by Evan Rappaport. This topic contains 1,743 news and 329 blog items. Read updated news, blogs, and resources about Pharmaceutical Approvals. Find user-submitted articles and reactions on Pharmaceutical Approvals from like-minded professionals.

Blogs

Recent blog posts on this topic.

2012's New Drugsmore

Thanks to Lisa Jarvis at C&E News, here's a chart (PDF) of the 39 drugs approved last year by the FDA.

2012's New Drugsmore

Thanks to Lisa Jarvis at C&E News, here's a chart (PDF) of the 39 drugs approved last year by the FDA.

The Name of a Curemore

Here's an excellent article at Slate on "natural" medicines versus pharmaceuticals. You won't see too many...

All Those Drug-Likeness Papers: A Bit Too Neat to be True?more

There's a fascinating paper out on the concept of "drug-likeness" that I think every medicinal chemist should...

DUCTS: Down with Useless Clinical Trial acronymSmore

I'm not the first person to complain about these things, of course. Even by 2003, there were sixteen different clinical...

Trouble Hiring Whom, Exactly?more

Here's a report on employment in the biopharma industry that will cause some pretty strong emotions in those of us who...

Mipomersen Approved (Bonus Antisense Roundup Included)more

So Isis and their partner Sanofi have received FDA approval for mipomersen (branded as Kynamro). Late last year, the...

Mipomersen Approved (Bonus Antisense Roundup Included)more

So Isis and their partner Sanofi have received FDA approval for mipomersen (branded as Kynamro). Late last year, the...

Dr. Oz's Problemmore

Red palm oil. Green coffee beans. Raspberry ketone. Some of you are wondering what the heck I'm making for dinner, but...

Time to Refill Your Prescription For Zxygjfbmore

The brand names of drugs are famously odd. But they seem to be getting odder. That's the conclusion of a longtime...

Time to Refill Your Prescription For Zxygjfbmore

The brand names of drugs are famously odd. But they seem to be getting odder. That's the conclusion of a longtime...

That Many Compounds in Development? Really?more

So PhRMA has a press release out on the state of drug research, but it's a little hard to believe. This part,...

More on Metformin and Cancer (and Alzheimer's)more

Metformin: what a weird compound it is. Very small, very polar, the sort of thing you'd probably cross off your list of...

Another Reactive Oxygen Papermore

Picking up on that reactive oxygen species (ROS) business from the other day (James Watson's paper suggesting that it...

Bright, Glowing Industrial Chemistrymore

If you haven't seen it yet, this video tour through the DayGlo company's facilities is quite a sight. For us chemists,...

Overselling p53 Drugsmore

You may have seen some "wonder drug" news stories over the holiday break about compounds targeting p53 - many...

Overselling p53 Drugsmore

You may have seen some "wonder drug" news stories over the holiday break about compounds targeting p53 - many...

Merck's Tredaptive Comes to a Haltmore

Merck's Tredaptive (formerly Cordaptive) has had a long and troubled history. It's a combination of niacin and...

Merck's Tredaptive Comes to a Haltmore

Merck's Tredaptive (formerly Cordaptive) has had a long and troubled history. It's a combination of niacin and...

Lilly's Two-Drugs-a-Year Predictionmore

Drug research consultant Bernard Munos popped in the comments here the other day and mentioned this story from 2010 in...

Lilly's Two-Drugs-a-Year Predictionmore

Drug research consultant Bernard Munos popped in the comments here the other day and mentioned this story from 2010 in...

Dr. Gilman's Turn Toward the Insidemore

Remember that story last month about insider trading on the Wyeth bapineuzumab Alzheimer's results? Dr.

LaMattina on Angellmore

John LaMattina takes on Marcia Angell and her recent interview. It sounds like he made it farther into the podcast than...

LaMattina on Angellmore

John LaMattina takes on Marcia Angell and her recent interview. It sounds like he made it farther into the podcast than...

Eli Lilly's Brave Alzheimer's Talkmore

I'm a bit baffled by Eli Lilly's strategy on Alzheimer's. Not the scientific side of it - they're going strongly after...

Top Sources: Pharmaceutical Approvals

  • SeekingAlpha.com: Home Page
  • DODTracker.com New Deals Feed
  • stockerblog.blogspot.com
  • What's New at CBER
  • RSS from PharmiWeb.com
  • futurebiopharma.blogspot.com
  • In the Pipeline
  • FDA Law Blog
  • Health News from Medical News Today
  • Medical Device Recalls since November 11, 2009

Most Active Users in this Topic

see all contributors in Pharmaceutical Approvals

Featured White Papers

Post a Job

Jobs in this Topic

Pharmaceutical Project Manager Cempra Pharmaceuticals | Chapel Hill, NC
Posted: Jun 11
Associate Director, Drug Regulatory Affairs Product Group Boehringer Ingelheim | Ridgefield, CT
Posted: Jun 3
SCIENTIST IV, PHARMACEUTICAL R&D Boehringer Ingelheim | Connecticut
Posted: May 28
Pharmaceutical Sales Specialist - TO PC2 AstraZeneca | Great Falls, MT
Posted: Jun 17
Executive Pharmaceutical Sales Specialist (Manhattan North, NY) Shire Pharmaceuticals | Chesterbrook, PA
Posted: May 17

Report comment contains invalid characters. ()
cancel
Search Cancel